The urinary catheter is the tube made from latex, polyurethane or silicon, this catheter is inserted into the bladder through urethra the process is called catheterization. The catheter allows the draining of the urine from the bladder for collection. It is also used for the injection of liquid for the diagnosis or treatment of the different bladder conditions. A urinary catheter is recommended by the doctor for different medical conditions which include urinary incontinence, surgery on prostate or genitals, urinary retention, and other medical conditions. Different types of catheters are available in the market such as foley, intermittent, and external catheters. Some patients with urinary tract infections are also recommended to use a urinary catheter. According to Centres for Disease Control and Prevention, 75.00% of patients with urinary tract infections are associated with urinary catheters. The use of a urinary catheter is relatively simple, it is an effective solution for the bladder infections if used correctly, it is safe to use, Foley catheter causes minor infection but Intermittent catheter this side effect is greatly reduced, and they are also inexpensive. Bladder diseases are increasing among the age group above 50 years. The Urinary Catheter Market is accounted approximate USD 2.3 billion in 2020 and it is expected to reach approximate USD 5.2 billion by 2030 with a CAGR of 8.5% during forecast period.
Market Segmentation:
On the basis of product, the urinary catheter market is segmented into intermittent, foley, and external. On the basis of coating, the market is segmented into coated and uncoated. On the basis of indication, the market is segmented into urinary incontinence, benign prostate hyperplasia, bladder dysfunction, and spinal cord injury. And by region, the urinary catheter market is segmented into North America, Europe, Asia Pacific, and RoW.
Market Dynamics and Factors:
Increasing bladder infections and urinary incontinence among the populace are some of the major factors which are assisting in the growth of the market. In addition to that ease to use is another supporting factor. With proper instruction or training, self-catheterization is also possible. According to the World Health Organisation (WHO) in 2017 prevalence of urinary incontinence, cases were reported to 9.9% to 36.1% after analysing some population-based study. The presence of elder population also increases the demand for the market. However, sometimes bacteria enter into the body through a catheter which could cause infection. The growing healthcare sector and development of advanced materials will create opportunities in years to come.
Geographic Analysis:
North America has dominated the market with major shares of the urinary catheter market and it is expected to continue its dominance during the forecast period. North America has a well-established healthcare sector with better infrastructure. In addition to this, awareness of urinal dysfunction amongst the populace and availability of advanced technology for diagnosis. All these factors boost the growth of the market in the region. Europe is also expected to witness growth with significant CAGR due to an increase in patients of the bladder and urinary infection. An increase in the number of surgeries performed in a region further boosts the market. Asia Pacific will witness significant growth due to the rising occurrences of urinary and bladder infections combined with the growing healthcare sector in the region.
Competitive Scenario:
The key players in the global urinary catheter market are Hollister Incorporated, Boston Scientific Corporation, Teleflex Incorporation, Cure Medical, Cr Brad Inc., and Cook Medical, Compactcath, Convatec, Coloplast A/S, Bioderm, And B. Braun Melsungen Ag.
Urinary Catheter Market Report Scope
Report Attribute | Details |
Analysis Period | 2020–2030 |
Base Year | 2021 |
Forecast Period | 2022–2030 |
Market Size Estimation | Billion (USD) |
Growth Rate (CAGR%) | 8.5 % |
| By Product (Intermittent, Foley, and External), By Coating (Coated and Uncoated), By Indication (Urinary Incontinence, Benign Prostate Hyperplasia, Bladder Dysfunction, and Spinal Cord Injury) |
Geographical Segmentation | North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), South America (Brazil, Argentina, Rest of SA), MEA (UAE, Saudi Arabia, South Africa) |
Key Companies Profiled | Hollister Incorporated, Boston Scientific Corporation, Teleflex Incorporation, Cure Medical, Cr Brad Inc., and Cook Medical, Compactcath, Convatec, Coloplast A/S, Bioderm, And B. Braun Melsungen Ag. |